Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Advanced Therapies,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    Cerium catalyst breakthrough could streamline greener drug development

    Japanese researchers discover a way to perform two different chemical [...]

    May 5, 2026
  • Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Genomics and sequencing: Sapient study uses rLC-MS to map metabolic aging and disease insights in 26,000 samples

    Sapient has published a large-scale metabolomics study using its rapid [...]

    May 5, 2026
  • Advanced Therapies,Central Nervous System,Drug Discovery & Development

    $2.5M awarded to fuel breakthrough research into tau-driven neurodegenerative diseases

    The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer’s Association, and [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics

    Lungpacer receives CMS NTAP approval for AeroPace system, enhancing care for mechanically ventilated patients

    Lungpacer Medical has received CMS New Technology Add-on Payment approval [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain

    Envoy expands emergency notifications platform to bolster safety and compliance for pharma and biotech workplaces

    Envoy, a leading provider of workplace management technology, has introduced [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Nasus Pharma announces pricing of $10M initial public offering

    Nasus Pharma Ltd., a clinical-stage pharmaceutical company focused on developing [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Evogene and Tel Aviv University join forces to tackle metabolite aggregation in metabolic diseases

    Evogene Ltd. has announced a scientific collaboration with Professor Ehud [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    FoRx Therapeutics starts first-in-human trial of novel PARG inhibitor FORX-428 in advanced solid tumors

    FoRx Therapeutics has initiated a first-in-human clinical trial of FORX-428, [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Preclinical study shows evenamide targets schizophrenia pathology in the hippocampus

    Newron Pharmaceuticals has highlighted new preclinical findings published in Neuropsychopharmacology [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    InflaRx targets key data readouts for INF904 in skin conditions

    InflaRx has reported its Q2 2025 results and provided updates [...]

    May 5, 2026
Previous565758Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • QuantHealth raises $45M Series B to expand AI clinical trial simulation
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Research & Development
  • Circio advances circular RNA gene therapy platform towards clinical development
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Research & Development
  • Jascayd approval expands treatment options for pulmonary fibrosis in Europe
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top